Amundi’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-439,037
Closed -$94M – 2102
2023
Q3
$94M Buy
439,037
+144,147
+49% +$28.8M 0.05% 369
2023
Q2
$57.3M Buy
294,890
+20,430
+7% +$4.06M 0.03% 484
2023
Q1
$56.3M Sell
274,460
-83,235
-23% -$13.4M 0.03% 484
2022
Q4
$47.2M Buy
357,695
+132,380
+59% +$17.1M 0.03% 513
2022
Q3
$30.8M Buy
225,315
+141,317
+168% +$23M 0.02% 606
2022
Q2
$14.8M Buy
83,998
+1,078
+1% +$155K 0.01% 687
2022
Q1
$12.9M Sell
82,920
-10,144
-11% -$1.37M 0.01% 754
2021
Q4
$12.7M Buy
93,064
+17,419
+23% +$2.92M 0.01% 784
2021
Q3
$12.8M Buy
75,645
+6,139
+9% +$955K 0.01% 782
2021
Q2
$11M Buy
+69,506
New +$10.3M 0.01% 817

Other funds holding SGEN

Amundi's SGEN Position: Q4 2023 in Review

Amundi sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 439,037 shares — an estimated $94M sold.

Amundi first reported a position in SGEN in Q2 2021 and held it in 10 quarters. The position peaked at $94M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Amundi reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Amundi sold 439,037 Seagen Inc. Common Stock shares in Q4 2023, an estimated $94M.
  • Amundi first reported a position in Seagen Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Amundi's Seagen Inc. Common Stock position peaked at $94M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.